Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth

References

• Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004; 19: 307–319
   PubMedGoogle Scholar
• Namgung R, Tsang R C. Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization. Proc Nutr Soc 2000; 59: 55–63
   PubMed Web of Science ®Google Scholar
• Barker D J. Fetal origins of cardiovascular disease. Ann Med 1999; 31: 3–6
   PubMed Web of Science ®Google Scholar
• Hales C N, Barker D J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595–601
   PubMed Web of Science ®Google Scholar
• Terkelsen O B, Jahnen-Dechent W, Nielsen H, Moos T, Fink E, Nawratil P, Muller-Esterl W, Mollgard K. Rat fetuin: distribution of protein and mRNA in embryonic and neonatal rat tissues. Anat Embryol (Berl) 1998; 197: 125–133
   Google Scholar
• Dziegielewska K M, Matthews N, Saunders N R, Wilkinson G. alpha2HS-glycoprotein is expressed at high concentration in human fetal plasma CSF. Fetal Diagn Ther 1993; 8: 22–27
   PubMed Web of Science ®Google Scholar
• Putnam F W. Progress in plasma proteins. The Plasma Proteins, F W Putnam. Academic Press, New York, NY 1984; 1–44
   Google Scholar
• Dickson I R, Poole A R, Veis A. Localization of plasma alpha2HS glycoprotein in mineralising human bone. Nature 1975; 256: 430–432
   PubMed Web of Science ®Google Scholar
• Denecke B, Graber S, Schafer C, Heiss A, Woltje M, Jahnen-Dechent W. Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 2003; 376: 135–145
   PubMed Web of Science ®Google Scholar
• Dziegielewska K M, Brown W M, Deal A, Foster K A, Fry E J, Saunders N R. The expression of fetuin in the development and maturation of the hemopoietic and immune systems. Histochem Cell Biol 1996; 106: 319–330
   PubMedGoogle Scholar
• Nie Z. Fetuin: its enigmatic property of growth promotion. Am J Physiol 1992; 263: C551–C562
   PubMedGoogle Scholar
• Szweras M, Liu D, Partridge E A, Pawling J, Sukhu B, Clokie C, Jahnen-Dechent W, Tenenbaum H C, Swallow C J, Grynpas M D, Dennis J W. alpha2-HS glycoprotein/fetuin – a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J Biol Chem 2002; 277: 19991–19997
   PubMed Web of Science ®Google Scholar
• Mathews S T, Singh G P, Ranalletta M, Cintron V J, Qiang X, Goustin A S, Jen K L, Charron M J, Jahnen-Dechent W, Grunberger G. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 2002; 51: 2450–2458
   PubMed Web of Science ®Google Scholar
• Lebreton J P, Joisel F, Raoult J P, Lannuzel B, Roger J P, Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64: 1118–1129
   PubMed Web of Science ®Google Scholar
• Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003; 112: 357–366
   PubMed Web of Science ®Google Scholar
• Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, Jahnen-Dechent W. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 1996; 271: 20789–20796
   PubMed Web of Science ®Google Scholar
• Ombrellino M, Wang H, Yang H, Zhang M, Vishnubhakat J, Frazier A, Scher L A, Friedman S G, Tracey K J. Fetuin, a negative acute phase protein, attenuates TNF synthesis and the innate inflammatory response to carrageenan. Shock 2001; 15: 181–185
   PubMedGoogle Scholar
• Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany G M, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I, Winkler G. Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol 2002; 147: 243–248
   PubMed Web of Science ®Google Scholar
• Stefan N, Hennige A M, Staiger H, Machann J, Schick F, Krober S M, Machicao F, Fritsche A, Haring H U. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006; 29: 853–857
   PubMed Web of Science ®Google Scholar
• Fiore C E, Celotta G, Politi G G, Di Pino L, Castelli Z, Mangiafico R A, Signorelli S S, Pennisi P. Association of high alpha(2)-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis 2006; 195: 110–115
   Google Scholar
• Dickson I R, Bagga M, Paterson C R. Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein – a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta. Calcif Tissue Int 1983; 35: 16–20
   PubMed Web of Science ®Google Scholar
• Gardosi J, Chang A, Kaylan B, Sahota D, Symonds E M. Customised antenatal growth charts. Lancet 1992; 339: 283–287
   PubMed Web of Science ®Google Scholar
• Kaminopetros P, Higueras M T, Nicolaides K H. Doppler study of uterine artery blood flow: comparison of findings in the first and second trimesters of pregnancy. Fetal Diagn Ther 1991; 6: 58–64
   PubMedGoogle Scholar
• Acharya G, Wilsgaard T, Berntsen G K, Maltau J M, Kiserud T. Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol 2005; 192: 937–944
   PubMed Web of Science ®Google Scholar
• Baschat A A, Galan H L, Bhide A, Berg C, Kush M L, Oepkes D. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol 2006; 27: 41–47
   PubMed Web of Science ®Google Scholar
• Burkhardt T, Schaffer L, Schneider C, Zimmermann R, Kurmanavicious J. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol 2006; 128: 248–252
   PubMed Web of Science ®Google Scholar
• Namgung R, Tsang R C. Bone in the pregnant mother and newborn at birth. Clin Chim Acta 2003; 333: 1–11
   PubMed Web of Science ®Google Scholar
• Cooper C, Javaid M K, Taylor P, Walker-Bone K, Dennison E, Arden N. The fetal origins of osteoporotic fracture. Calcif Tissue Int 2002; 70: 391–394
   PubMed Web of Science ®Google Scholar
• Harrast S D, Kalkwarf H J. Effects of gestational age, maternal diabetes, and intrauterine growth retardation on markers of fetal bone turnover in amniotic fluid. Calcif Tissue Int 1998; 62: 205–258
   Google Scholar
• Binkert C, Demetriou M, Sukhu B, Szweras M, Tenenbaum H C, Dennis J W. Regulation of osteogenesis by fetuin. J Biol Chem 1999; 274: 28514–28520
   PubMed Web of Science ®Google Scholar
• Colclasure G C, Lloyd W S, Lamkin M, Gonnermann W, Troxler R F, Offner G D, Burgi W, Schmid K, Nimderg R B. Human serum alpha 2HS-glycoprotein modulates in vitro bone resorption. J Clin Endocrinol Metab 1988; 66: 187–192
   Google Scholar
• Suzuki M, Shimokawa H, Takagi Y, Sasaki S. Calcium-binding properties of fetuin in fetal bovine serum. J Exp Zool 1994; 270: 501–507
   Google Scholar
• Lehtinen A B, Burdon K P, Lewis J P, Langefeld C D, Ziegler J T, Rich S S, Register T C, Carr J J, Freedman B I, Bowden D W. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis. J Clin Endocrinol Metab 2007; 92: 345–352
   PubMed Web of Science ®Google Scholar
• Ix J H, Shlipak M G, Brandenburg V M, Ali S, Ketteler M, Whooley M A. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 2006; 113: 1760–1767
   PubMed Web of Science ®Google Scholar
• Karamessinis P M, Malamitsi-Puchner A, Boutsikou T, Makridakis M, Vougas K, Fountoulakis M, Vlahou A, Chrousos G. Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications. Mol Cell Proteomics 2008; 7: 591–599
   Google Scholar